Mouse miR-290 cluster miRNAs are expressed specifically in early embryos and embryonic germ cells. These miRNAs play critical roles in the maintenance of pluripotency and self-renewal. Here, we showed that Cyclin D1 is a direct target gene of miR-290 cluster miRNAs. Negative relationships between the expression of Cyclin D1 protein and miR-290 cluster miRNAs in pluripotent and non-pluripotent cells, as well as in differentiating CGR8 cells were observed. Inhibition of miR-290 cluster miRNAs could arrest cells at the G1 phase and slow down the cell proliferation in CGR8 mouse stem cells. Since miR-290 cluster miRNAs are the most dominant stem-cell-specific miRNAs, our results revealed an important cause for the absence of Cyclin D1 in mouse embryonic stem cells.
Introduction
Embryonic stem cells (ESCs) express a unique pattern of miRNAs that are associated with pluripotency [1] [2] [3] [4] . The miR-290 cluster is the most abundant miRNA family in mouse ESCs (mESCs) and includes miR-290a-3p, miR-291a-3p, miR-291b-3p, miR-292-3p, miR-294-3p, and miR-295-3p [5] [6] [7] . These miRNAs are transcribed as a 3.3 k nt-long primary transcript which is processed into >10 mature miRNAs. These mature miRNAs exhibit high sequence similarity with one another [8] . The expression of the miR-290 family miRNAs occurs at as early as the two-to four-cell stage, and rises steadily until the blastula stage, before plunging during differentiation [9, 10] . Transcriptional control of this mESC-specific miRNA cluster is mediated by c-Myc and four genes that make up the core transcription factor regulatory network in ESCs. These four genes include octamer-binding transcription factor 4 (Oct4), SRY-box 2 (Sox2), Nanog homeobox (Nanog), and transcription factor 3 (Tcf3) [5, 11, 12] .
Deficiency of this miRNA cluster shows partially penetrant embryonic lethality and defective germ cells in mouse [13] . There are many studies indicating the physiological importance of miR-290 cluster miRNAs in mESCs. Members of this cluster can rescue G1 phase arrest and proliferation defects in Dicer -/-and Dgcr8
-/-mESCs [14] . Moreover, miR-290 cluster miRNAs enhance Oct4, Sox2, and KLF4 (Kruppel like factor 4) iPSC (induced pluripotent stem cell) colony formation to an extent of 70-folds increases in reprograming efficiency [11] . These miRNAs have also been reported to promote rapid proliferation by regulating the pluripotent stem cell cycle. For instance, they accelerate G1/S transition by targeting cyclindependent kinase inhibitor 1A (p21), large tumor suppressor kinase 2 (Lats2), and RB transcriptional corepressor like 2 (Rbl2), which are inhibitors of the cyclin E-Cdk2 pathway [14] . Wee1 (WEE1 G2 checkpoint kinase) which encodes a regulatory kinase of the G2/M cell cycle checkpoint is also targeted by miR-290 cluster miRNAs [15] . Additionally, these miRNAs repress mESC differentiation by post-transcriptional targeting of RELA proto-oncogene (p65), dickkopf WNT signaling pathway inhibitor 1 (Dkk-1), and paired box 6 (Pax6) [16] [17] [18] . However, contradictory findings have also suggested that the miR-290 cluster miRNAs may enable early differentiation indirectly via suppression of Rbl2 [19] . Furthermore, miR-290 cluster miRNAs prevent apoptosis of mESC from genotoxic stress by direct repression of two novel targets, i.e. Caspase 2 and Ei24 (autophagy associated transmembrane protein) [20] . Together, these studies revealed important yet complicated roles for the miR-290 cluster in modulating the pluripotency of mESCs. However, the genes mentioned above are certainly not the sole targets of the miR-290 cluster miRNAs, and since miR-290 cluster miRNAs are the most dominant miRNA family which contributes to 60%-70% of expressed miRNAs in mESCs [5, 6] , their target genes should not limit to those mentioned above. Thus, exploring more novel targets of this cluster miRNAs would be helpful to further elucidate their roles in mESCs. The typical mammalian cell cycle consists of four phases: G1, S, G2, and M. DNA is replicated in S phase and the chromosomes are separated into two new nuclei during M phase. G1 and G2 are the 'gap' phases for the upcoming of S phase and M phase, respectively. Two cell cycle kinase complexes, Cyclin-dependent kinase 4 (CDK4)/6-Cyclin D and Cyclin-dependent kinase 2 (CDK2)-Cyclin E, work in concert as a primary G1/S cell cycle checkpoint to control the G/S transition of eukaryotic cells [21] . There are three cyclin D isoforms, i.e. D1, D2, and D3, which bind to CDK4 and CDK6. Among them, cyclin D1 (CCDN1) is the most widely expressed one. The p16 (cyclin-dependent kinase inhibitor 2A)-cyclin D1-CDK4-Rb pathway is central to the regulation of the G1/S phase transition in normal cell cycle [22] . Unlike somatic cells, the cell cycle structure of ESCs is very unusual and consists mainly of S phase cells and a short G1 phase [21] . In human ES cells, all G1-specific cyclins (D1, D2, D3, and E) and CDK, i.e. CDK2, CDK4, and CDK6, are expressed cell cycledependently [23] . However, in mouse ES cells, the cyclin D1 protein is expressed at an extra low level and the Cdk4/Cdk6-Cyclin D complex is not present [24] [25] [26] [27] . Therefore, murine ES cells show more rapid cell cycle than human ES cells due to the absence of the G1/S restriction point.
In the present study, we showed that Ccnd1 is a target gene of miRNA-290 cluster miRNAs and is repressed by these miRNAs. Inhibition of these miRNAs in CGR8 mouse stem cells will result in the repression of G1/S transition of cell cycle and cell proliferation. Therefore, Ccnd1 might be substantially repressed in mESCs due to the very high level of miR-290 cluster miRNAs. This mechanism is presumed to be, at least partially, responsible for the absence of the Cdk4/Cdk6-Cyclin D activity and the rapid cell cycle in mESCs.
Materials and Methods

Cell culture, transfection, and treatment
The mESC line, CGR8, was obtained from Dr Ting Li (Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) and cultured in GMEM medium (Invitrogen, Carlsbad, USA) supplemented with 15% fetal bovine serum (FBS; Invitrogen), 1000 U/ml leukemia inhibitor factor (LIF; Millipore, Billerica, USA), 0.1 mM nonessential amino acids (Invitrogen), 0.1 μM beta-mercaptoethanol (Invitrogen), and 2 mM of L-glutamine (Invitrogen). Medium was refreshed daily and cells were subcultured every other day using 0.05% Trypsin (Sigma, St Louis, USA). Prior to use, culture ware was coated with 0.1% gelatin (Sigma). The mouse neuroblastoma cells (N 2 A) and the 293T cells were from Cell Bank of Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and were both cultured in DMEM medium (Invitrogen) with 10% FBS (Invitrogen). 
RNA extraction and quantification by real-time PCR
Total RNA was extracted with TRIzol reagent (Invitrogen) as described in the manufacturer's instructions, and then reverse transcribed using the One Step PrimeScript miRNA cDNA Synthesis Kit (TaKaRa, Otsu, Japan) according to the manufacturer's protocol. Realtime PCR was performed using SYBR Premix Ex Taq (TaKaRa) according to the user's manual. The sequences of the miRNA-specific primers were 5′-AAAGTGCTTCCACTTTGTGTGC-3′ (miR-291a-3p), 5′-AAAGTGCTTCCCTTTGTGTGT-3′ (miR-294-3p), and 5′-AAA GTGCTACTACTTTTGAGTCT-3′ (miR-295-3p). The U6 RNA primer sequences were 5′-CTCGCTTCGGCAGCACA-3′ (U6-Forwad) and 5′-AACGCTTCACGAATTTGCGT-3′ (U6-Reverse). The relative levels of miRNAs were calculated using the 2 −ΔΔCt method after normalization to U6 reference RNA. For mRNA analysis, the PrimeScript RT reagent Kit and the SYBR Premix Ex Taq (TaKaRa) were used with the following primers: Ccnd1-Forward: 5′-GCGTACCCTGACACCAATCTC-3′; Ccnd1-Reverse: 5′-CTCCTCTTCGCACTTCTGCTC-3′; Oct4-Forward: 5′-GGCTTCAGACTTCGCCTCC-3′; Oct4-Reverse: 5′-AACCTGAGG TCCACAGTATGC-3′; 18S-Forward: 5′-CTGCCGTCTGAGTGTATC GC-3′; 18S-Reverse: 5′-GCTGGGGCTGAGGAAAGTG-3′. The mRNA expression levels were calculated using the 2 −ΔΔCt method after normalization to 18S rRNA. All real-time PCRs were performed on a CFX96 Real-Time System (Bio-Rad, Hercules, USA).
Western blot analysis
Samples were prepared with pre-chilled RIPA buffer and resolved on 15% SDS-polyacrylamide gels and then transferred to polyvinylidene difluoride membranes (Millipore, Billerica, USA). Membranes were blocked with 3% bovine serum albumin in tris-buffered saline with Tween 20 (TBST). Membranes were incubated with primary antibodies against Ccnd1 and Oct4 which were purchased from Cell Signaling Technology (Danvers, USA) and with anti-GAPDH antibody (Santa Cruz, Santa Cruz, USA), followed by incubation with the corresponding HRP-conjugated secondary antibodies (Santa Cruz). Chemical luminescence development was performed with Immobilon Western Chemiluminescent HRP Substrate (Millipore) and images were captured with a ChemiDoc™ XRS + System, followed by analysis using Image Lab 3.0 (Bio-Rad, Hercules, USA).
Cell proliferation analysis
The proliferation of CGR8 cells was assessed using a Cell Counting Kit-8 (CCK-8) (Dojindo, Kumamoto, Japan). Briefly, cells were seeded in 96-well plates at the concertration of 1 × 10 4 cells per well, cultured overnight, and transfected with indicated miRNAs or inhibitors. After 8 h transfection, 100 μl of fresh culture medium containing 10 μl of CCK-8 reagent was added to each well, followed by incubation for 2 h at 37°C. The absorbance at 450 nm was determined using a Microplate Reader (Bio-Rad).
Cell cycle assay
For cell cycle analysis, CGR8 cells were transfected with miRNA inhibitors (200 nM). After 48 h treatment, the cells were fixed with 70% pre-chilled ethanol at −20°C overnight. The cells were then stained with 50 μg/ml of propidium iodide and 50 μg/ml RNase A (Sigma) for 30 min. The cell cycle assay was performed on a MoFlo XDP flow cytometry system (Beckman Coulter, Indianapolis, USA) and analyzed with Flowjo software (TreeStar Inc., Ashland, USA).
Plasmid construction and site-directed mutagenesis
The sequences of the 3′ UTRs of potential target genes were cloned into the downstream of the luciferase gene on the pGL3-promoter vector (Promega, Madison, USA). Primers used for 3′ UTR cloning are listed in 
Luciferase assay
Cells were transfected with 400 ng of firefly luciferase reporter plasmids, 20 ng of renilla luciferase reference plasmid, and 60 nM of miR-290 cluster miRNAs in 24-well plates. At 48 h after cotransfection, cells were lysed and luciferase activity was analyzed on an Orion L Microplate Luminometer (Titertek-Berthold, Pforzheim, Germany) using the Dual Luciferase Assay System (Promega). Relative luciferase activity was calculated by normalizing firefly luciferase activity to renilla luciferase activity.
In vitro differentiation of GCR8 cells
In vitro differentiation of GCR8 cells was performed as previously described [28, 29] . Briefly, 3 × 10 6 CGR8 cells were plated onto non-adherent bacterial dishes (Greiner, Frickenhausen, Germany) in EB medium (stem cell culture medium mentioned above, without LIF) for embryoid body formation. Medium was changed every 2 days. After 4 days of culture, retinoic acid (RA) was added at a concentration of 5 μM and cultured for 4 more days. On the eighth day, embryoid bodies were dissociated and cells were plated on poly-D-lysine and laminin coated plates in N2 medium (Invitrogen). After 2 days, medium was replaced by complete medium to terminate neuronal differentiation.
Statistical analysis
Data are shown as the mean ± SEM from three independent experiments. Statistical significances were evaluated by one-way ANOVA. P < 0.05 was considered significant difference.
Results
In vitro validation of potential target genes of miR-290 cluster miRNAs
Previous studies reported that three inhibitors of the cyclin E-Cdk2 pathway, i.e. p21, Lats2, and Rbl2, and a regulatory kinase of the G2/M cell cycle checkpoint, i.e. Wee1, are target genes of miR-290 cluster miRNAs [14, 19] . The online tools, TargetScan and microRNA.org, were employed to predict more potential target genes of miR-290 cluster miRNAs that are involved in cell cycle [30, 31] . Eight predicted target genes involving in cell cycle regulation were chosen for further validation ( Table 1) . Among them, Wee1 and Fbxl5 (F-box and leucine rich repeat protein 5) were previously reported as target genes of miR-290 cluster miRNAs [15] . The 3′ UTRs of these mRNAs, bearing the predicted binding sites, were cloned into downstream of the luciferase coding sequence on pGL3 reporter vectors. These reporter constructs were cotransfected with miR-291a-3p, miR-294-3p, miR-295-3p, or negative control miRNA. These miRNAs moderately repressed Mbd2 and Wee1 by~15%-25% and 18%-23%, respectively (Fig. 1) , and strongly inhibited the luciferase activities of the Myt11 and Ccnd1 F: CCGCTCTAGACGTCACCCTTTGCCTGAT R: CCCGGAATTCTGTCCAACTGTGCCCAAC constructs by~56%-67% and 46%-64%, respectively (Fig. 1) . The remaining constructs were repressed by~50% (Fig. 1) . MiR-294-3p was the most effective miRNA to inhibit these target genes, followed by miR-291a-3p and then miR-295-3p (Fig. 1 ).
Ccnd1 is a direct target gene of miR-290 cluster miRNAs
In order to determine whether Ccnd1 is negatively regulated by miR-290 cluster miRNAs through the predicted binding site on its 3′ UTR, a construct containing four base mutations at the binding site was generated as pGL3-Ccnd1-Mut (Fig. 2A) . As expected, the binding site mutation fully relieved the repression from transfection of miR-290 cluster miRNAs (Fig. 2B) . To test the repression of miR-290 cluster miRNAs on endogenous Ccnd1 protein, N2A cells, a mouse neuroblastoma cell line, were transfected with miR-291a-3p, miR-294-3p, miR-295-3p, or negative control miRNA. All three miR-290 cluster miRNAs inhibited endogenous Ccnd1 protein expression by~27%-48% in N2A cells (Fig. 2C) . On the contrary, endogenous Ccnd1 levels significantly increased by 2.8-to 3.2-folds after these miRNAs inhibitors were transfected into CGR8 cells (Fig. 2D) . The CGR8 mouse stem cell line is derived from germ-line pluripotent cells that retain the ability to participate in normal embryonic development and express a very high level of miR-290 cluster miRNAs (Fig. 3A) . Again, the best relief of repression on Ccnd1 expression was seen in the miR-294-3p inhibitor, with~3.2-folds increase of Ccnd1 protein level in CGR8 cells (Fig. 2D) . Taken together, these results verified that Ccnd1 may be a target gene of miR-290 cluster miRNAs.
An inverse expression pattern occurs between Ccnd1 and miR-290 cluster miRNAs
To explore whether Ccnd1 expression is inversely related to the levels of miR-290 cluster miRNAs, Ccnd1 mRNA and miR-290 cluster miRNAs in these two cell lines were determined. CGR8 mouse stem cells express a very high level of miR-290 cluster miRNAs, whereas N2A mouse neuroblastoma cells do not express these miRNAs (Fig. 3A) . The expression level of Ccnd1 mRNA in N2A cells was~2.3-folds higher than that in CGR8 cells (Fig. 3B) , while the protein level of Ccnd1 showed an~9.3-folds difference between these two cell lines (Fig. 3C) . These results revealed an inverse expression pattern for Ccnd1 and the miR-290 cluster in Figure 1 . MiR-290 cluster miRNAs inhibit the predicted target genes 3′ UTRs of the eight predicted target genes were cloned into downstream of the luciferase gene on pGL3 reporter vectors. For each well of a 24-well plate, 293T cells were co-transfected with either miR-291a-3p, miR-294-3p, miR-295-3p, or negative control mimics (NC) at a concentration of 60 nM, plus 400 ng of the pGL3-3′UTR constructs and 20 ng of pRL (renilla luciferase) plasmid. Luciferase activities were determined at 48 h after transfection. The relative firefly luciferase activities were calculated after normalization to the renilla activities. All these predicted target genes were repressed by miR-290 miRNAs with a P < 0.05. CGR8 and N2A cells, and also showed that the endogenous expression of CCND1 in CGR8 cells actually cannot be ignored. To further confirm this inverse correlation between the expression of the miR-290 cluster and Ccnd1, CGR8 cells were induced to differentiate into neuronal cells in the presence of RA [28] . In this protocol, CGR8 cells aggregated to form embryoid bodies on Day 4. RA was then added to induce embryoid bodies into neural precursors from Day 4 to Day 8. At the end of the induction, embryoid bodies were dissociated and cultured in N2 medium for 2 days. Cells with neuronal characteristics appear in <2 days after the dissociation of the embryoid bodies. During differentiation, both mRNA and protein levels of the pluripotent marker Oct4 were dramatically decreased to undetectable levels by Days 8 and 10, which indicated that successful differentiation was achieved (Fig. 4A,B) . Similarly, miR-290 cluster miRNAs were also decreased sharply with the loss of pluripotency upon RA induction after Day 4 (Fig. 4C) . There was little expression of the miR-290 cluster on Day 8 and this expression was further decreased to undetectable level on Day 10 of differentiation. Meanwhile, Ccnd1 protein level was increased to >4-folds on Day 8 and was further substantially increased to nearly 14-folds by Day 10 of differentiation (Fig. 4D) . Collectively, these results demonstrated a negative correlation between the expression of the miR-290 cluster and Ccnd1 during in vitro differentiation of CGR8 cells.
Notably, the expression pattern of Ccnd1 protein was inconsistent with its mRNA during the differentiation of CGR8 cells. Ccnd1 mRNA level kept steady on Day 0 as well as Day 4, and was only increased moderately on Days 8 and 10, to around 2-folds (Fig. 4E) . To further clarify this point, we evaluated the relative ratio of Ccnd1 protein level to its mRNA level, and found that there was no significant difference between on Day 0 and Day 4 ( Fig. 4F) , but by Day 8, the relative ratio was increased to~2.3-folds in the differentiating CGR8 cells, reaching~7.2-folds on Day 10 (Fig. 4F) . The discrepancy between Ccnd1 protein level and mRNA level indicated that post-transcriptional regulation is involved. It has been shown that Ccnd1 is a target gene of miR-290 cluster miRNAs and miRNA-miR290 cluster miRNAs are expressed at very high level in mESCs [5, 6] . Therefore, repression of the abundant miR-290 cluster miRNAs should be an important post-transcriptional inhibition of 
Inhibition of miR-290 cluster miRNAs arrests mESCs in G1 phase
One of the classical characteristics of stem cells is a high rate of proliferation, which is a result of rapid cell cycle. Unlike human stem cells, mESCs lack the Cdk4/Cdk6-cyclin D complex due to extremely low level of Ccnd1. To explore the role of miR-290 in mESCs, the distribution of cell cycle phases were analyzed after miR-290 clusters miRNAs were inhibited in CGR8 cells. Inhibition of any single miR-290 cluster miRNA (miR-291a-3p, miR-294-3p, or miR-295-3p) could effectively arrest~12%-28% more CGR8 cells at G1 phase, resulting in~5%-19% less S phase cells, as compared with the negative control (Fig. 5) . Transfection of the mixture of all three miRNAs inhibitors showed the most significant arrest of cell cycle over transfection of any single miRNA inhibitor, with almost 34% more G1 phase CGR8 cells. These results indicated that miR-290 cluster miRNAs contributed to the rapid G1/S phase transition in mESCs, and that inhibition of these miRNAs substantially arrested mESCs in G1 phase.
Inhibition of MiR-290 cluster miRNAs reduces mESCs proliferation
Given that inhibition of miR-290 cluster miRNAs could slow down the cell cycle in mESCs, a reduced proliferation was threrefore expected. To confirm this point, miR-290 cluster inhibitors were introduced into CGR8 cells and a moderate repression of proliferation was achieved (Fig. 6) . The inhibitors showed~7% repression of proliferation in the CGR8 cells at 72 h after transfection, and reached 12%-15% repression at 96 h post-transfection with statistical significances (Fig. 6) . Transfection of mixture inhibitors of miR-291a-3p, miR-294-3p, and miR-295-3p into CGR8 cells resulted in more significant repression of proliferation (~15% and 23% at 72 and 96 h post-transfection, respectively) than transfection of any single miRNA inhibitor (Fig. 6) . These results showed that inhibition of miR-290 cluster miRNAs could repress cell proliferation of mEScs.
Discussion
The most dominant ES cell-specific miRNAs in the miR-290 cluster were considered to play important roles in the activities necessary for the maintenance of pluripotency, such as self-renewal and rapid proliferation. In this study, inhibitors of miR-291a-3p, miR-294-3p, and miR-295-3p were introduced into CGR8 mESCs, and all were found to suppress proliferation and cell cycle. However, transfection of these three miR-290 cluster miRNAs promoted proliferation and cell cycle in N2A cells. Our data showed that there was a synergistic effect among these miR-290 cluster miRNAs, which is consistent with previous studies [14, 32] , suggesting that the miR-290 cluster promotes cell cycle and proliferation in ES cells. The three miRNAs studied here have the same seed sequence and similar 3′ UTRs. The complementarity between seed sequence and mRNA is the dominant contributor for target recognition [33] . This seed rule is commonly used by many target prediction algorithms [34] , and thus the predicted target gene lists are almost the same for the three miRNAs. However, although they are predicted to target many common genes, a synergistic effect on the promotion of proliferation indicates that these miRNAs must have diverse target genes. The transfection with the combination of these miRNAs resulted in repression of a broader group of genes than transfection with a single miRNA, which in turn manifested a synergistic enhancement on the modulation of proliferation. This is also in agreement with considerable evidence for the existence of many 'non-seed' target sites of high biological relevance [35] . Therefore, to better search for these diverse target genes, non-seed-based prediction algorithms should be used instead of the seed-based algorithms [34] . We believe that these diverse target genes will be useful to improve our understanding of the physiological role of miR-290 cluster miRNAs.
ESCs exhibit a very unusual cell cycle structure, consisting mainly of an S phase and a short G1 phase, but lack of a G1/S checkpoint. Cdk2-cyclin E is considered as the principle CDK which controls the G1/S transition of murine ESCs, and is highly active throughout the cell cycle [36] . Three inhibitors of the Cdk2-cyclin E pathway, i.e. p21, Lats2, and Rbl2, were reported to be the target genes of miR-290 cluster miRNAs [14] , and miR-290 cluster miRNAs could promote the transition of ES cells from G1 to S phase by modulating the Cdk2-cyclin E pathway. MiR-290 cluster miRNAs were also reported to target Wee1, a key kinase regulator at the G2/M cell cycle checkpoint [32] . Wee1 inhibits Cdk1 activity and prevents cells from entering mitosis [37] . However, because miR-290 cluster miRNAs are considered to inhibit up to hundreds of target genes, it is expected they should have even more influence on cell cycle regulation. To explore the additional roles of miR-290 cluster miRNAs in cell cycle regulation, we predicted their target genes by TargetScan and MicroRNA.org [30, 31] . Eight genes related to cell cycle were validated to be recognizable by miR-290 cluster miRNAs. Thus, the miR-290 cluster miRNAs do in fact seem to regulate cell cycle to a greater degree than first considered.
Somatic cells spend >50% of time in G1 phase, and overcoming the G1/S restriction checkpoint is required for transition out of G1 into S phase [38] . Two cell cycle kinase complexes, CDK4/6-cyclin D and CDK2-cyclin E, work successively to regulate the G1/ S checkpoint and transition. In human ESCs, all G1-specific cyclins (D1, D2, D3, and E) and cyclin-dependent kinases (CDK2, CDK4, and CDK6) are expressed cell cycle-dependently [23] . Human cyclin D1 was reported to be a target of miR-302, a member of human ES cell-specific microRNA family [39] . However, the Cdk4/Cdk6-cyclin D complex is not present in mESCs [26, 27] . This implies that there is a difference between the cell-cycle mechanisms regulated by these ES cell-specific miRNAs through cyclin D1 in human and mESCs. In this study, we showed that miR-290 cluster miRNAs are involved in the regulation of the CDK4/6-cyclin D checkpoint via targeting cyclin D1. Due to the very high level of expression of miR-290 cluster miRNAs in ESCs, their target genes, including cyclin D1, could be largely repressed. As a result, it is reasonable to speculate that the absence of a CDK4/6-cyclin D checkpoint in mESCs may be attributed to the solid suppression of cyclin D1 caused by miR-290 cluster miRNAs. Our study revealed a new potential role for miR-290 cluster miRNAs in the G1/S transition of mouse ES cells.
